The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
Rhea-AI Summary
The Oncology Institute (NASDAQ:TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference in Marina Del Rey, CA, on May 21, 2026.
A fireside chat is scheduled from 9:00–9:40 a.m. PT and will be available via webcast on the company’s investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – TOIIW
In the May 13 session, TOIIW gained 19.76%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 07 | Earnings results | Positive | +33.3% | Strong Q1 2026 revenue growth and narrowed net loss with better EBITDA. |
| Apr 27 | Earnings date set | Neutral | -0.4% | Announced timing and access details for Q1 2026 earnings call. |
| Apr 13 | Medicare savings | Positive | +56.0% | Reported higher CMS Enhancing Oncology Model Medicare savings and quality scores. |
| Apr 09 | Conference participation | Neutral | -1.9% | Management participation in Needham Healthcare Conference with webcast access. |
| Apr 06 | Leadership change | Positive | +15.8% | Appointment of Chief Legal Officer to oversee legal and compliance functions. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent fundamentally positive updates (earnings strength, Medicare savings) tended to coincide with strong positive price reactions, while more routine items like conference participation have seen muted or slightly negative moves.
Over the last few months, The Oncology Institute reported strong Q1 2026 results, with revenue and gross profit growing and net loss narrowing, which was followed by a notable positive price reaction. Earlier, it highlighted $1.8 million in Medicare savings with improved per-episode performance, also drawing a strong upside move. By contrast, announcements on conference participation and an earnings date generated minimal or slightly negative reactions. A leadership addition at Chief Legal Officer level drew a positive response, underscoring investor focus on substantive operational and financial progress.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B. Riley Securities Institutional Investor Conference, being held in Marina Del Rey, CA on Thursday, May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
____________________________
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
